In audiology, we describe listening environments using the signal-to-noise ratio (SNR). The signal is what you want to hear—like your conversation partner—and noise is everything you don’t want to hear.

As someone hard of hearing, I intimately understand the challenges of a world not always designed for me. This drives my mission to advocate for better access and representation.

While significant challenges remain, ongoing efforts in genetic research, immunology, and clinical trials offer hope for better management and potential cures for Ménière’s disease in the future.

Because of the increased network depth, upscaled input resolution, and the ability to perform well in a limited data setting, our new imaging model aided by machine learning outperformed previous state-of-the-art models predicting cochlear implant success outcomes.

Even though I may not hear every note perfectly, playing in a band has been a powerful experience. I connect with music not just through the sound of my trumpet but through feeling, vibration, and the very essence of music itself. 

As always we are so thrilled to meet and catch up with our funded scientists, past and present, at this important research conference.

“Mara Hears in Style” is the book I wish my three children had when they were young and newly diagnosed with hearing loss. I wrote the book so that children who wear hearing aids will see themselves in a book and be seen, but I also wanted Mara's character to be relatable to all children.

Despite challenges, the potential of machine learning to improve cochlear implant outcomes is clear. By refining models, improving data quality, and addressing ethical concerns, we can move toward a future where CIs are more personalized and effective. 

The impact of noise on hearing depends on both volume and duration. The louder the noise, the faster it can cause damage.

This research shows that it is possible to design gene therapies for the ear that are carefully targeted at supporting cells, an essential first step in applying targeted gene therapies to treat hearing loss in humans.